Premium Information is available for this item - Upgrade for $1 a day
6505-01-201-3413
Propranolol Hydrochloride Extended-Release Capsules
6505012013413 012013413 INDERAL LA NDC00046-0473-99
January 2023
6
Marketplace 6505-01-201-3413
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-201-3413 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-201-3413 RQST Updated Every Day 6505-01-201-3413 RQST NE Related Documents
/fsg-65 6505012013413012013413,INDERAL LA 34136505012013413012013413,INDERAL LA 6505012013413012013413
6505012013413 012013413,INDERAL LA 6505-01-201-34136505012013413012013413,INDERAL https//www.nsnlookup.com
65/fsc-6505/us 6505-01-191-9014 6505011919014011919014011919014 163-7908 6505011919015011919015,INDERAL LA
6505012013413 012013413,INDERAL LA 6505011637908011637908,,NDC42291-0525-01 Documents 6505-01-163
-7908 5+ Documents ( More... https 6505012013413012013413,INDERAL LA 34136505012013413012013413,INDERAL
CAPSULES 98377 - Pfizer Inc. https //www.nsnlookup.com 6505011919015011919015,INDERAL LA CAPSULES
65/fsc-6505/us 6505-01-201-3413 6505012013413 012013413,INDERAL LA ,INDERAL LA 6505012013413012013413
CAPSULES 98377 - Pfizer Inc. https //www.nsnlookup.com 6505011919015011919015,INDERAL LA CAPSULES
https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-201-3413 6505012013413 012013413,INDERAL LA ,INDERAL
Restrictions 6505-01-201-3413
6505-01-201-3413 is a Propranolol Hydrochloride Extended-Release Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-201-3413
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-201-3413
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-201-3413
- Part Number
- Manufacturer
- Status
- NDC00046-0473-99
- Manufacturer
- 98377 - Pfizer Inc. (Active)
- Primary Buy
- Primary Buy
- INDERAL LA
- 98377 - Pfizer Inc. (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-201-3413
- Characteristic
- Specifications
- FIIG
- Specifications
- A510U0
- Active Medicament Medicinal Strength [AKJA]
- Unable To Decode
- Capsule Type [AKJC]
- Unable To Decode
- Long Action Method [AKJF]
- Unable To Decode
- Primary Container Type [CQCT]
- Unable To Decode
- Capsule Content Form [CQLS]
- Unable To Decode
- Administration [CSGS]
- Unable To Decode
- Special Features [FEAT]
- Unable To Decode
Management Data 6505-01-201-3413
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- May 1990
- Veterans Administration (VA)
- PG
- Subscribe
- PG
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 100 Ea
- 00000000100EA
- K
NATO Stock Numbers Related to 6505-01-201-3413
Freight Information 6505-01-201-3413
6505-01-201-3413 has freight characteristics.. 6505-01-201-3413 has a variance between NMFC and UFC when transported by rail and the description should be consulted.